SCHEMBL20012919

SCHEMBL20012919

CC(=O)N1CCN(c2ccc(Nc3ncc(I)c(-n4ccnc4)n3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 1/20 0.58
▸ SYK P43405 14/20 0.56
▸ JAK2 O60674 1/20 0.55
▸ JAK1 P23458 1/20 0.55
▸ TYK2 P29597 1/20 0.55
▸ JAK3 P52333 1/20 0.55
▸ CDK2 P24941 3/20 0.51
▸ IGF1R P08069 1/20 0.51
▸ CDK4 P11802 2/20 0.49
▸ CCND1 P24385 1/20 0.49
▸ CCNE1 P24864 1/20 0.49
▸ AURKA O14965 1/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CDK7 P50613 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ AURKB Q96GD4 1/20 0.49
▸ WEE1 P30291 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20012904 0.87 CDK4 (0.54) ALKJAK2CDK2CDK4CCND1
SCHEMBL20012903 0.84 SYK (0.53) SYKJAK2JAK1TYK2JAK3
SCHEMBL20012936 0.81 WEE1 (0.47) SYKJAK2JAK1JAK3CDK4
SCHEMBL20012909 0.79 PDGFRB (0.50) ALKJAK2CDK2IGF1RCDK4
SCHEMBL20012906 0.77 CDK4 (0.46) SYKJAK2JAK1TYK2JAK3
SCHEMBL3934496 0.76 CYP17A1 (0.67) —
SCHEMBL20012916 0.76 JAK2 (0.60) ALKJAK2CDK2CDK4AURKA
SCHEMBL20012911 0.75 EGFR (0.57) ALKJAK2CDK4AURKACDK1
SCHEMBL20012912 0.75 ALK (0.62) ALKJAK2JAK3CDK2IGF1R
SCHEMBL20012950 0.75 AURKA (0.54) ALKSYKJAK2CDK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018056621-A1 NOVEL IMIDAZOLYL PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2018-03-29 — — WO disclosed
Send feedback